| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146987 Nucleotide sequences coding chloramphenicol acetyltransferase, luciferase, beta-glucuronidase or beta-galactosidase gnetically engineered fusion polypeptide with reduced half-life of expression; diagnostic tools for genetic and disease analysis |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146985 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146980 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof |
| 07/29/2004 | US20040146978 Isolated human Ras-like proteins, nucleic acid molecules encoding human Ras-like proteins, and uses thereof |
| 07/29/2004 | US20040146977 Production of heterologous proteins from Zygosaccharomyces bailii |
| 07/29/2004 | US20040146976 Transforming microorganism and monitoring expression of heterologous proteins on cell surface; monitoring protein-protein interactions and identifying modulators for treating autoimmune and cell proliferative diseases |
| 07/29/2004 | US20040146975 Promoter variants for expressing genes in a fungal cell |
| 07/29/2004 | US20040146974 Method for producing L-amino acid using methylotroph |
| 07/29/2004 | US20040146972 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/29/2004 | US20040146969 Process for producing recombinant protein and fused protein |
| 07/29/2004 | US20040146968 Three dimensional structure of human derived apoptotic factor and receptor thereof x-ray crystallography and trail deletion mutant protein |
| 07/29/2004 | US20040146967 Novel g protein-coupled receptor protein and dna thereof |
| 07/29/2004 | US20040146966 Mutations affecting carotenoid production |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146952 T cell receptors mutants that have higher affinity for the peptide/MHC ligand than the wild type; can be used in place of an antibody or single chain antibody |
| 07/29/2004 | US20040146948 single-chain variable region fragment (scFv) comprising a heavy chain variable region (VH) operably linked to a light chain variable region (VL); for cancer treatment |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146939 for drug screening using animal models for regulating one or more proteins involved in growth, proliferation, and metabolism; solid phase synthesis; genetic engineering |
| 07/29/2004 | US20040146935 Disease associated gene |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146931 for detecting protein-protein, protein-DNA, or protein-RNA interactions; for drug screening or screening libraries with greater than 107 members; used in conjunction with flow cytometry; solid phase synthesis; kits |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146928 Human neuronal attachment factor-1 |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146922 on a genome-wide scale using a genome-registered gene fusion collection, which are amenable to rapid assay and may be used to confirm, correct or augment data generated |
| 07/29/2004 | US20040146914 comprising bromodomains and the encoding gene; for anticancer agents; genetic engineering |
| 07/29/2004 | US20040146911 Method for the uncoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application |
| 07/29/2004 | US20040146904 Vascular-preferred promoter sequences and uses thereof |
| 07/29/2004 | US20040146902 oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex |
| 07/29/2004 | US20040146892 Expression vector coding organelle transport protein for use in identifying modulators of adenine nucleotide translocator and cyclophilin d interaction |
| 07/29/2004 | US20040146891 Comprises growth factor for diagnosis and treatment of immunological and cell proliferative disorders |
| 07/29/2004 | US20040146889 Inducible regulatory system and use thereof |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146886 DNA probes, method and kit for identifying antibiotic-resistant strains of bacteria |
| 07/29/2004 | US20040146884 Antifreeze proteins isolated from forage grasses and methods for their use |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146879 Novel human genes and gene expression products |
| 07/29/2004 | US20040146878 Identifying muscular disorder using amplified mutant gene sequences; genetic mapping |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146876 Complex element micro-array and methods of use |
| 07/29/2004 | US20040146875 Detecting nucleotide sequence variation between alleles/heteroduplex DNA; restriction fragment length polymorphisms |
| 07/29/2004 | US20040146874 Disposable biochip for determining nucleotide sequence beyond specified primer; DNA sequencing and analysis |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146871 Beadmilling the sample in a beadmilling buffer to disrupt cells in the sample and extracting RNA, DNA or protein from the sample using a solid phase extraction; ribonuclease inhibitor in the beadmilling buffer is guanidium isothiocyanate |
| 07/29/2004 | US20040146867 Compounds and processes for single-pot attachment of a label to siRNA |
| 07/29/2004 | US20040146865 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 07/29/2004 | US20040146864 Joining DNA sequences using topoisomerase I |
| 07/29/2004 | US20040146859 Nucleotide sequences coding hemorrhagic viral protein for use in detection and treatment of viral diseases; viricides; genetic vaccines |
| 07/29/2004 | US20040146858 Viral expression vector for elucidation of gene structure and function; gene expression inhibition; apoptosis/necrosis preventatives; viricides |
| 07/29/2004 | US20040146856 Viral vector coding antiproliferative agent for treatment of tumors; antitumor agents and artificial chromosome gene therapy |
| 07/29/2004 | US20040146854 Attenuated forms of bovine viral diarrhea virus |
| 07/29/2004 | US20040146533 Useful for vaccinating |
| 07/29/2004 | US20040146531 Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells |
| 07/29/2004 | US20040146528 MVA expressing modified HIV envelope, gag, and pol genes |
| 07/29/2004 | US20040146527 Pertussis toxin gene: cloning and expression of protective antigen |
| 07/29/2004 | US20040146525 Shellfish protein |
| 07/29/2004 | US20040146519 For use in vaccines, prophylaxis and therapy of cancer |
| 07/29/2004 | US20040146516 Lumen-exposed molecules and methods for targeted delivery |
| 07/29/2004 | US20040146510 Genetically engineered polypeptides as wound healing agents; treatment of nervous system, vision, kidney, and liver disorders; stimulating embryogenesis and angiogenesis; antitumor agents; drug screening, diagnosis |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146505 Polypeptide comprising portion with part of human fc fragment which binds to CD64 antigen, and portion comprising heterologous T cell epitopes; antitumor and anticarcinogenic agents |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146501 Polynucleotides, recombinant vectors and host cells for gene expression; antibody fragments |
| 07/29/2004 | US20040146489 Replication competent adenovirus vectors comprising co-transcribed first and second genes under transcriptional control of a heterologous, target cell-specific transcriptional regulatory element (TRE) |
| 07/29/2004 | US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents |
| 07/29/2004 | US20040146487 Avidin pseudotyped viral vectors and their use |
| 07/29/2004 | US20040146486 One unit engineered to constitutively express co-stimulator and another can be engineered to express single, fusion or multiple antigens derived from disease causing pathogen |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | US20040144397 Modifying nicotine and nitrosamine levels in tobacco |
| 07/29/2004 | US20040144155 Compositions and methods for removing pollutants from contaminated water with a fern plant |
| 07/29/2004 | DE10302421A1 New double-stranded interfering RNA, useful for inhibiting hepatitis C virus, has one strand linked to a lipophilic group to improve activity and eliminate the need for transfection auxiliaries |
| 07/29/2004 | DE10045016B4 Retrovirale Vektoren mit Fremdsequenzinsertion zwischen retroviraler Primerbindungsstelle und retroviralem Spleißdonor Retroviral vectors with Fremdsequenzinsertion between retroviral primer binding site and retroviral splice donor |
| 07/29/2004 | CA2513249A1 Method for in vivo regulation of cardiac muscle contractility |
| 07/29/2004 | CA2513226A1 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 07/29/2004 | CA2513168A1 Methods and compositions for producing male sterile plants |
| 07/29/2004 | CA2513072A1 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 07/29/2004 | CA2513034A1 Targeted transgenesis using the rosa26 locus |
| 07/29/2004 | CA2513025A1 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/29/2004 | CA2512717A1 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | CA2512693A1 Novel proteins with altered immunogenicity |
| 07/29/2004 | CA2512676A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 07/29/2004 | CA2512673A1 2-o sulfatase compositions and related methods |
| 07/29/2004 | CA2512590A1 Kunitz domain library |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/29/2004 | CA2512392A1 Human calcium transporter 1 gene, screening method of calcium absorption regulating factor, and calcium absorption regulating factor |
| 07/29/2004 | CA2512337A1 Sirna mediated post-transcriptional gene silencing of genes involved in alopecia |
| 07/29/2004 | CA2512151A1 Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 07/29/2004 | CA2511853A1 Novel fibulin-like polypeptides |
| 07/29/2004 | CA2510401A1 Defensin proteins |
| 07/29/2004 | CA2509422A1 Method for preparing recombinant heterocarpine |
| 07/29/2004 | CA2482850A1 A method for the evaluation of hair-growth promoting activity |
| 07/28/2004 | EP1441036A1 Method for the identification and isolation of strong bacterial promoters |
| 07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |